Optimi Health Completes Psilocybin Export to Australia for Treatment Resistant Depression @Optimi_Health #MDMA #psilocybin #psychedelics #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Australia #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
Vancouver, British Columbia--(Newsfile Corp. - February 19, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of pharmaceutical-grade psychedelic drug products, today announced the export of its GMP-manufactured natural 5 mg psilocybin capsules to Australia for the treatment of patients diagnosed with treatment-resistant depression (TRD) under Australia's Authorised Prescriber Scheme.The shipment represents...
http://dlvr.it/TR2k4X
http://dlvr.it/TR2k4X
Comments
Post a Comment